Methotrexate Solution
Product Images NDC 0143-9517

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 0143-9517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Methotrexate Injection Usp 1)

Chemical structure of Methotrexate showing its molecular framework including a pteridine ring, amino groups, a benzene ring, and carboxyl functional groups.*

FDA Label Image

Methotrexate Injection, Usp 50 mg/2 mL Vial Label (Methotrexate Injection Usp 2)

Methotrexate Injection, USP 25 mg/mL single-dose vial label by Hikma Pharmaceuticals USA Inc. This sterile toxic agent solution provides preservative-free methotrexate for intra-arterial, intramuscular, intrathecal, and intravenous use. The label includes barcode, storage instructions protecting from light and storing at 20 to 25 degrees Celsius, and warnings about prescribing information and dosage.*

FDA Label Image

Methotrexate Injection, Usp 100 mg/4 mL Vial Label (Methotrexate Injection Usp 3)

Methotrexate Injection, USP 100 mg per 4 mL (25 mg/mL) solution for injection by intramuscular or subcutaneous use. The label states it is a cytotoxic agent and highlights warnings about dosing and medication errors. The labeler is Hikma Pharmaceuticals USA Inc., with NDC 0143-9518-01.*

FDA Label Image

Methotrexate Injection, Usp 200 mg/8 mL Vial Label (Methotrexate Injection Usp 4)

Methotrexate Injection, USP 25 mg/mL solution in a single-dose vial. This preservative-free, sterile isotonic solution is labeled for intravenous, intramuscular, intrathecal, or subcutaneous use. The vial contains 8 mL, providing a total of 200 mg per vial. Manufactured by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Methotrexate Injection, Usp 250 mg/10 mL Vial Label (Methotrexate Injection Usp 5)

Methotrexate Injection USP 25 mg per 10 mL (2.5 mg/mL) sterile isotonic solution in a vial. The label states it is preservative-free and intended for intravenous, intramuscular, intrathecal, or subcutaneous use. It includes warnings about dosage and storage conditions. Labeler is Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Representative Carton Serialization Image (Methotrexate Injection Usp 6)

Label panel displaying a QR code and alphanumeric identifiers including GTIN, serial number, expiration date placeholder, and lot number placeholder for Methotrexate 25 mg/mL solution by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Representative Carton Serialization Image (Methotrexate Injection Usp 7)

Label for Methotrexate solution 25 mg/mL by Hikma Pharmaceuticals USA Inc. The label includes a 2D barcode, a lot number, expiration date, GTIN (Global Trade Item Number), and a serial number. The label is designed for identification and traceability purposes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.